Advertisement

Head and Neck Pathology

, Volume 11, Issue 1, pp 68–77 | Cite as

Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors

  • John M. WrightEmail author
  • Marilena Vered
Original Paper
Part of the following topical collections:
  1. World Health Organization Classification Update

Abstract

The 4th edition of the World Health Organization’s Classification of Head and Neck Tumours was published in January of 2017. This article provides a summary of the changes to Chapter 4 Tumours of the oral cavity and mobile tongue and Chapter 8 Odontogenic and maxillofacial bone tumours. Odontogenic cysts which were eliminated from the 3rd 2005 edition were included in the 4th edition as well as other unique allied conditons of the jaws. Many new tumors published since 2005 have been included in the 2017 classification.

Keywords

Odontogenic cysts odontogenic tumors Gnathic conditions Gnathic bone tumors WHO Classification Update on WHO Classification of odontogenic tumors 

Notes

Compliance with Ethical Standards

Conflict of interest

Neither Drs. Wright nor Vered have anything to disclose regarding potential conflicts of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

This article does not require Informed consent.

References

  1. 1.
    Koutlas IG, Allen CM, Warnock GR, Manivel JC. Sclerosing odontogenic carcinoma: a previously unreported variant of a locally aggressive odontogenic neoplasm without apparent metastatic potential. Am J Surg Pathol. 2008;39:1613–19.CrossRefGoogle Scholar
  2. 2.
    Irie T, Ogawa I, Takata T, Toyosawa S, Saito N, Akiba M, et al. Sclerosing odontogenic carcinoma with benign fibro-osseous lesion of the mandible: an extremely rare case report. Pathol Int. 2010;60:694–700.CrossRefPubMedGoogle Scholar
  3. 3.
    Bilodeau EA, Weinreb I, Antonescu CR, Zhang L, Dacic S, Muller S, et al. Clear cell odontogenic carcinomas show EWSR1 rearrangements: a novel finding and a biological link to salivary clear cell carcinoma. Am J Surg Pathol. 2013;37:1001–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Yancoskie AE, Sreekantaiah C, Jacob J, Rosenberg A, Edelman M, Antonescu CR, et al. EWSR1 and ATF1 rearrangements in clear cell odontogenic carcinoma: presentation of a case. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:e115–e8.CrossRefPubMedGoogle Scholar
  5. 5.
    Kunkel M, Ghalibafian M, Radner H, Reichert TE, Fischer B, Wanger W. Ameloblastic fibrosarcoma or odontogenic carcinosarcoma: a matter of classification. Oral Oncol. 2004;40:444–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Slater LJ. Odontogenic sarcoma and carcinosarcoma. Semin Diagn Pathol. 1999;16:325–32.PubMedGoogle Scholar
  7. 7.
    DeLair D, Bejarano PA, Peleg M, El-Mofty SK. Ameloblastic carcinosarcoma of the mandible arising in ameloblastic fibroma: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:516–20.CrossRefPubMedGoogle Scholar
  8. 8.
    Mosqueda-Taylor A, Neville BW, Tatemoto Y, Ogawa I, Takata T. Odontogenic carcinoma with dentinoid: a new odontogenic carcinoma. Head Neck Pathol. 2014;8:421–31.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kurppa KF, Caton J, Morgan PR, Ristimaki A, Ruhin B, Kellokoski J, Elenius K, Heikinheimo K. High frequency of BRAF V600E mutations in ameloblastoma. J Pathol. 2014;232:492–8.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S, Odegaard JI, Sugiyama T, Koyota S, Rubin BP, Troxell ML, Pelham RJ, Zehnder JL, Beachy PA, Pollack JR, West RB. Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 2014;46:722–5.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, Elenitoba-Johnson KS, Betz BL. Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res. 2014;20:5517–26.CrossRefPubMedGoogle Scholar
  12. 12.
    Kumamoto H, Ohki K, Ooya K. Expression of Sonic hedgehog (SHH) signaling molecules in ameloblastomas. J Oral Pathol Med. 2004;33:185–90.CrossRefPubMedGoogle Scholar
  13. 13.
    Dassule HR, Lewis P, Bei M, Maas R, McMahon AP. Sonic hedgehog regulates growth and morphogenesis of the tooth. Development. 2000;127:4775–85.PubMedGoogle Scholar
  14. 14.
    Heikinheimo K, Jee KJ, Niini T, Aalto Y, Happonen RP, Leivo I, Knuutila S. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res. 2002;81:525–30.CrossRefPubMedGoogle Scholar
  15. 15.
    Pereira NB, Pereira KM, Coura BP, Diniz MG, de Castro WH, Gomes CC, Gomez RS. BRAFV600E mutation in the diagnosis of unicystic ameloblastoma. J Oral Pathol Med. 2016. doi: 10.1111/jop.12443.Google Scholar
  16. 16.
    Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–54.CrossRefPubMedGoogle Scholar
  17. 17.
    Parada LF, Land H, Weinberg RA, Wolf D, Rotter V. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature. 1984;312:649–51.CrossRefPubMedGoogle Scholar
  18. 18.
    Li Y, Mangasarian K, Mansukhani A, Basilico C. Activation of FGF receptors by mutations in the transmembrane domain. Oncogene. 1997;14:1397–406.CrossRefPubMedGoogle Scholar
  19. 19.
    Diniz MG, Gomes CC, Guimarães BV, Castro WH, Lacerda JC, Cardoso SV, de Faria PR, Dias FL, Eisenberg AL, Loyola AM, Gomez RS. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours. Tumour Biol. 2015;36:5649–53.CrossRefPubMedGoogle Scholar
  20. 20.
    Brown NA, Betz BL. Ameloblastoma: a review of recent molecular pathogenetic discoveries. Biomark. Cancer. 2015;7(Suppl 2):19–24.Google Scholar
  21. 21.
    Kaye FJ, Ivey AM, Drane WE, Mendenhall WM, Allan RW. Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma. J Natl Cancer Inst. 2014;107:378.CrossRefPubMedGoogle Scholar
  22. 22.
    Robinson L, Martinez MG. Unicystic ameloblastoma: a prognostically distinct entity. Cancer. 1977;40:2278–85.CrossRefPubMedGoogle Scholar
  23. 23.
    Ackermann GL, Altini M, Shear M. The unicystic ameloblastoma: a clinicopathological study of 57 cases. J Oral Pathol. 1988;17:541–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Philipsen HP, Reichart PA. Unicystic ameloblastoma. A review of 193 cases from the literature. Oral Oncol. 1998;34:317–25.CrossRefPubMedGoogle Scholar
  25. 25.
    Li T-J, Wu Y-T, Yu S-F, Yu G-Y. Unicystic ameloblastoma. A clinicopathologic study of 33 Chinese patients. Am J Surg Pathol. 2000;10:1385–92.CrossRefGoogle Scholar
  26. 26.
    Vered M, Shohat I, Buchner A, Dayan D. Myofibroblasts in stroma of odontogenic cysts and tumors can contribute to variations in the biological behavior of lesions. Oral Oncol. 2005;41:1028–33.CrossRefPubMedGoogle Scholar
  27. 27.
    Gu XM, Zhao HS, Sun LS, Li TJ. PTCH mutations in sporadic and Gorlin–syndrome-related odontogenic keratocysts. J Dent Res. 2006;85:859–63.CrossRefPubMedGoogle Scholar
  28. 28.
    Li TJ, Yuan JW, Gu XM, Zhao HS. PTCH germline mutations in Chinese nevoid basal cell carcinoma syndrome patients. Oral Dis. 2008;25:174–9.CrossRefGoogle Scholar
  29. 29.
    Sun LS, Li XF, Li TJ. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors. J Dent Res. 2008;87:575–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Pan S, Li TJ. Mechanisms of inactivation of PTCH1 gene in keratocystic odontogenic tumors: modifivation of the two-hit hypothesis. Clin Cancer Res. 2010;16:442–50.CrossRefPubMedGoogle Scholar
  31. 31.
    Barreto DC, Gomez RS, Bale AE, Boson WL, De Marco L. PTCH gene mutations in odontogenic keratocysts. J Dent Res. 2000;79:1418–22.CrossRefPubMedGoogle Scholar
  32. 32.
    Ohki K, Kumamoto H, Ichinohasama R, Sato T, et al. PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts. Int J Oral Maxillofac Surg. 2009;33:584–92.CrossRefGoogle Scholar
  33. 33.
    Song YL, Zhang WF, Peng B, Wang CN, et al. Germline mutations of the pTCH ggene in families with odontogenic keratocysts and nevoid basal cell carcinoma syndrome. Tumor Biol. 2006;27:175–80.CrossRefGoogle Scholar
  34. 34.
    Agaram NP, Collins B, Barnes L, Lomago D, et al. Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. Arch Pathol Lab Med. 2004;128:313–7.PubMedGoogle Scholar
  35. 35.
    Henley J, Summerlin D-J, Tomich C, Zhang S, Cheng L. Molecular evidence supporting the neoplastic nature of odontogenic keratocyst: a laser capture microdissection study of 15 cases. Histopathology. 2005;47:582–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Malcic´ A, Jukic´ S, Anic´ I, Pavelic´ B, et al. Alterations of FHIT and p53 genes in keratocystic odontogenic tumours, dentigerous cyst and radicular cyst. J Oral Pathol Med. 2008;37:294–301.CrossRefPubMedGoogle Scholar
  37. 37.
    Pogrel MA, Jordan RC. Marsupialization as a definitive treatment for the odontogenic keratocyst. J Oral Maxillofac Surg. 2004;62:651–5.CrossRefPubMedGoogle Scholar
  38. 38.
    Diniz MG, Galvao CF, Macedo PS, Gomes CC, Gomez RS. Evidence of loss of heterozygosity of the PTCH gene in orthokeratinized odontogenic cyst. J Oral Pathol Med. 2011;40:277–80.CrossRefPubMedGoogle Scholar
  39. 39.
    Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, et al. Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clin Cancer Res. 2014;20:5517–26.CrossRefPubMedGoogle Scholar
  40. 40.
    Galvão CF, Gomes CC, Diniz MG, Vargas PA, de Paula AM, Mosqueda-Taylor A, et al. Loss of heterozygosity (LOH) in tumour suppressor genes in benign and malignant mixed odontogenic tumours. J Oral Pathol Med. 2012;41:389–93.CrossRefPubMedGoogle Scholar
  41. 41.
    Slootweg PJ. An analysis of the interrelationship of the mixed odontogenic tumors-ameloblastic fibroma, ameloblastic fibroodontoma, and the odontomas. Oral Surg Oral Med Oral Pathol. 1981;51:266–77.CrossRefPubMedGoogle Scholar
  42. 42.
    Philipsen HP, Reichart PA, Praetorius F. Mixed odontogenic tumours and odontomas. Considerations on interrelationship. Review of the literature and presentation of 134 new cases of odontomas. Oral Oncol. 1997;33:86–99.CrossRefPubMedGoogle Scholar
  43. 43.
    Buchner A, Vered M. Ameloblastic fibroma: a stage in the development of a hamartomatous odontoma or a true neoplasm? Critical analysis of 162 previously reported cases plus 10 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116:598–606.CrossRefPubMedGoogle Scholar
  44. 44.
    Ledesma-Montes C, Gorlin RJ, Shear M, Praetorius F, et al. International collaborative study on ghost cell odontogenic tumours: calcifying cystic odontogenic tumour, dentinogenic ghost cell tumour and ghost cell odontogenic carcinoma. J Oral Pathol Med. 2008;37:302–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Mosqueda-Taylor A, Pires FR, Aguirre- Urízar JM, Carlos-Bregni R, de la Piedra- Garza JM, Martínez-Conde R, et al. Primordial odontogenic tumour: clinicopathological analysis of six cases of a previously undescribed entity. Histopathology. 2014;65:606–12.CrossRefPubMedGoogle Scholar
  46. 46.
    Slater LJ, Eftimie LF, Herford AS. Primordial odontogenic tumor: report of a case. J Oral Maxillofac Surg. 2016;74:547–51.CrossRefPubMedGoogle Scholar
  47. 47.
    Bishop JA, Yonescu R, Batista D, Warnock GR, Westra WH. Glandular odontogenic cysts (GOCs) lack MAML2 rearrangements: a finding to discredit the putative nature of GOC as a precursor to central mucoepidermoid carcinoma. Head Neck Pathol. 2014;8:287–90.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Amary MF, Ye H, Forbes G, Damato S, Halai D, Berisha F, et al. Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas. Virchows Arch. 2015;466:217–22.CrossRefPubMedGoogle Scholar
  49. 49.
    Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge J, et al. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer. 2012;51:127–39.CrossRefPubMedGoogle Scholar
  50. 50.
    Yoshida A, Ushiku T, Motoi T, Shibata T, Beppu Y, Fukayama M, et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol. 2010;23:1279–88.CrossRefPubMedGoogle Scholar
  51. 51.
    Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45:1479–82.CrossRefPubMedGoogle Scholar
  52. 52.
    Flucke U, Tops BB, van Diest PJ, Slootweg PJ. Desmoid-type fibromatosis of the head and neck region in the paediatric population: a clinicopathologic and genetic study of seven cases. Hstopathology. 2014;64:769–76.CrossRefGoogle Scholar
  53. 53.
    E Horvai A, C Jordan R. Fibro-osseous lesions of the craniofacial bones; β –catenin immunohistochemical analysis and CT-NNB1 and APC mutation analysis. Head Neck. 2014;8:291–97.CrossRefGoogle Scholar
  54. 54.
    Marie PJ. Cellular and molecular basis of fibrous dysplasia. Histol Histopathol. 2001;16:981–8.PubMedGoogle Scholar
  55. 55.
    Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer. 1994;73:1411–24.CrossRefPubMedGoogle Scholar
  56. 56.
    Romeo S, Hogendoorn PC, Dei Tos AP. Benign cartilaginous tumors of bone: from morphology to somatic and germline genetics. Adv Anat Pathol. 2009;16:307–15.CrossRefPubMedGoogle Scholar
  57. 57.
    Presneau N, Baumhoer D, Behjati S, Pillay N, Tarpey P, Campbell P, et al. Diagnostic value of H3F3A mutations in giant cell tumor of bone compared to osteoclast-rich mimics. J Pathol. 2015;1:113–23.Google Scholar
  58. 58.
    Mangion J, Rahman N, Edkins S, Barfoot R, Nguyen T, Sigurdsson A, et al. The gene for cherubism maps to chromosome 4p16.3. Am J Hum Genet. 1999;65:151–7.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi BL, et al. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol. 2004;165:1773–80.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  1. 1.Department of Diagnostic SciencesTexas A&M University, School of DentistryDallasUSA
  2. 2.Department of Oral Pathology and Oral Medicine, School of Dental MedicineTel Aviv UniversityTel AvivIsrael
  3. 3.Institute of PathologyChaim Sheba Medical CenterRamat GanIsrael

Personalised recommendations